Rituximab for lymphocyte-predominant Hodgkin’s disease

被引：0
|
作者：
Carol S. Portlock
机构：
来源：
Current Oncology Reports | 2003年 / 5卷 / 5期
关键词：
Eastern Cooperative Oncology Group Performance; Partial Responder; Cooperative Oncology Group Performance Status; Hodgkin Disease; Chop Chemotherapy;
D O I：
10.1007/s11912-003-0018-6
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：358 / 358
相关论文
共 50 条
  • [21] Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's disease
    Diehl, V
    Sextro, M
    Franklin, J
    Hansmann, ML
    Harris, N
    Jaffe, E
    Poppema, S
    Harris, M
    Franssila, K
    van Krieken, J
    Marafioti, T
    Anagnostopoulos, I
    Stein, H
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 776 - 783
  • [22] Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma
    Grace Suh
    Anas Younes
    Nature Clinical Practice Oncology, 2008, 5 : 368 - 369
  • [23] Prognosis and outcomes of lymphocyte-predominant Hodgkin's lymphoma
    Suh, Grace
    Younes, Anas
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 368 - 369
  • [24] Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature
    Stier, James R.
    Vasquez, Robert J.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [25] Nodular lymphocyte-predominant Hodgkin lymphoma
    Tsai, Henry K.
    Mauch, Peter M.
    SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (03) : 184 - 189
  • [26] Nodular lymphocyte-predominant Hodgkin lymphoma
    Fuchs M.
    Eichenauer D.A.
    Nogová L.
    Diehl V.
    Engert A.
    Current Hematologic Malignancy Reports, 2008, 3 (3) : 126 - 131
  • [27] Nodular lymphocyte-predominant Hodgkin lymphoma
    Subhawong, Andrea P.
    Ali, Syed Z.
    Tatsas, Armanda D.
    CANCER CYTOPATHOLOGY, 2012, 120 (04) : 254 - 260
  • [28] Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Eichenauer, Dennis A.
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 : 19 - 20
  • [29] Nodular lymphocyte-predominant Hodgkin lymphoma
    Savage, Kerry J.
    Mottok, Anja
    Fanale, Michelle
    SEMINARS IN HEMATOLOGY, 2016, 53 (03) : 190 - 202
  • [30] Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Bocchia, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 831 - 833
12345